Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Faderl

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cytokines, Cellular & Molecular Therapy|January 21, 2000
The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemiaS Faderl, Z Estrov, H M Kantarjian, et al.
Leukemia & Lymphoma|October 6, 2007
The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathyConstantine S Tam, Susan O'Brien, Susan Lerner, et al.
Leukemia|June 9, 1999
Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implicationsB S Dabaja, S Faderl, D Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemiaD A Thomas, J Cortes, S O'Brien, et al.
Cancer|October 12, 2001
High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimensM Beran, Y Shen, H Kantarjian, et al.
Cancer|June 8, 2001
Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significanceF Ravandi, H M Kantarjian, M Talpaz, et al.
Leukemia|December 15, 2007
A prognostic score for patients with lower risk myelodysplastic syndromeG Garcia-Manero, J Shan, S Faderl, et al.
Leukemia|February 27, 2009
Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndromeR Garg, S Faderl, G Garcia-Manero, et al.
Bone Marrow Transplantation|January 20, 2009
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndromeL De Padua Silva, M de Lima, H Kantarjian, et al.
Leukemia & Lymphoma|November 9, 2001
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndromeB S Dabaja, S M O'Brien, H M Kantarjian, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cytokines, Cellular & Molecular Therapy|January 21, 2000
The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemiaS Faderl, Z Estrov, H M Kantarjian, et al.
Leukemia & Lymphoma|October 6, 2007
The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathyConstantine S Tam, Susan O'Brien, Susan Lerner, et al.
Leukemia|June 9, 1999
Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implicationsB S Dabaja, S Faderl, D Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemiaD A Thomas, J Cortes, S O'Brien, et al.
Cancer|October 12, 2001
High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimensM Beran, Y Shen, H Kantarjian, et al.
Cancer|June 8, 2001
Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significanceF Ravandi, H M Kantarjian, M Talpaz, et al.
Leukemia|December 15, 2007
A prognostic score for patients with lower risk myelodysplastic syndromeG Garcia-Manero, J Shan, S Faderl, et al.
Leukemia|February 27, 2009
Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndromeR Garg, S Faderl, G Garcia-Manero, et al.
Bone Marrow Transplantation|January 20, 2009
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndromeL De Padua Silva, M de Lima, H Kantarjian, et al.
Leukemia & Lymphoma|November 9, 2001
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndromeB S Dabaja, S M O'Brien, H M Kantarjian, et al.
Pageof 4